***Approval dates are my personal (pretty conservative too) projections, there is no specific commitment from FDA***
Focalin ROW partners 04/14
Update on Focalin sales q1 earning call 05/14
Rexista, Pristiq update 05/14
Protonix approval 06/14
Glucphage, Effexor, Protonix, Seroquel approvals between 06/14 & 12/14
Rexista submission by the end of 02/15
Lamictal, Keppra approvals between 06/15 &12/15